Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,680 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

1st Line Durvalumab in PS 2 NSCLC Patients

NCT03620669

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Kantonsspital Baden Baden, Switzerland
  • Universitaetsspital Basel Basel, Switzerland
  • IOSI Ospedale Regionale di Bellinzona e Valli Bellinzona, Switzerland
View Trial Details
Active, Not Recruiting

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors

NCT03893955

Conditions
Advanced Solid Tumors, Breast Diseases, Breast Neoplasms, +17 more
Locations
  • Highlands Oncology Group, PA /ID# 218863 Springdale, Arkansas, United States
  • St Jude Hospital dba St Joseph /ID# 211130 Santa Rosa, California, United States
  • Yale University School of Medicine /ID# 210678 New Haven, Connecticut, United States
  • Moffitt Cancer Center /ID# 215037 Tampa, Florida, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer

NCT06091943

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
View all 15 locations
View Trial Details
Active, Not Recruiting

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

NCT02273375

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • USC Norris/Comprehensive Cancer Centre Los Angeles, California, United States
  • National Jewish Health Denver, Colorado, United States
  • University of Florida Gainesville, Florida, United States
View all 271 locations
View Trial Details
Active, Not Recruiting

A Clinical Study to Evaluate the Efficacy and Safety of HLX26 (Anti-LAG-3 Monoclonal Antibody Injection) Combined With Serplulimab and Chemotherapy in Previously Untreated Advanced NSCLC Patients

NCT05787613

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Shanghai Chest Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Active, Not Recruiting

Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)

NCT05049044

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Centre Hospitalier d'Aix en Provence Aix-en-Provence, France
  • CHU Amiens-Picardie Amiens, France
  • Centre Hospitalier Universitaire Angers, France
  • Centre Hospitalier d'Annecy Annecy, France
View all 34 locations
View Trial Details
Active, Not Recruiting

Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer

NCT05403385

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Algemeen Ziekenhuis Sint-Lucas Ghent, Belgium
  • Jessa Ziekenhuis Hasselt, Belgium
View all 21 locations
View Trial Details
Active, Not Recruiting

Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

NCT06105021

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • USC Norris Comprehensive Los Angeles, California, United States
  • University of California Los Angeles Department of Medicine Los Angeles, California, United States
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States
View Trial Details

Related conditions